21 August 2020 : Clinical Research
Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade
Jingjing Chen12ACE, Shao Liu1ADE, Hui Xu23AF*, Wei Wang3BC, Yanyun Xie3B, Wenbin Tang3B, Qiongjing Yuan3B, Li Zheng4D, Lizhen Lin35F, Shuangshuang Fu6F, Jinmei Shen7CDOI: 10.12659/MSM.922839
Med Sci Monit 2020; 26:e922839
Figure 1 Kaplan-Meier analysis of survival in RASB treated and untreated patients. Progression to the primary outcome differed significantly (log-rank, p=0.004). RASB, rennin-angiotensin system blockers






